Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$85.45 USD

85.45
785,797

+1.33 (1.58%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $85.43 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks News

Zacks Equity Research

Do Options Traders Know Something About Alcon (ALC) Stock We Don't?

Investors need to pay close attention to Alcon (ALC) stock based on the movements in the options market lately.

Zacks Equity Research

Here's Why Alcon (ALC) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Reasons to Retain Alcon Stock in Your Portfolio for Now

Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.

Zacks Equity Research

Why Alcon (ALC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

ALC's performance is driven by robust demand for the company's innovative products, balanced geographic footprint and strong execution by the team.

Zacks Equity Research

Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alcon (ALC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.

Zacks Equity Research

Reasons to Retain Alcon Stock in Your Portfolio for Now

Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.

Zacks Equity Research

Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles

Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.

Zacks Equity Research

Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y

Alcon (ALC) delivers impressive growth in Implantables and Contact Lenses in the second quarter of 2024.

Zacks Equity Research

Alcon (ALC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Alcon's (ALC) Market Share Gains, New Launches Aid Growth

Alcon (ALC) is witnessing growth in its over-the-counter portfolio, driven by favorable pricing and a sustained family of products.

Zacks Equity Research

Countdown to Alcon (ALC) Q2 Earnings: Wall Street Forecasts for Key Metrics

Get a deeper insight into the potential performance of Alcon (ALC) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Equity Research

Philips (PHG) Extends Isala Partnership, Boosts Customer Base

Philips (PHG) extends its partnership Isala hospital to optimize the latter's healthcare processes, expanding its customer base.

Zacks Equity Research

McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y

McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.

Zacks Equity Research

Is Alcon (ALC) Outperforming Other Medical Stocks This Year?

Here is how Alcon (ALC) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.

Zacks Equity Research

Here's Why Alcon (ALC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.

Zacks Equity Research

Alcon (ALC) Rides on Innovation, Balanced Segmental Sales

Alcon (ALC) is witnessing growth in its over-the-counter portfolio, mainly driven by favorable pricing and a sustained family of products.

Nalak Das headshot

Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H

We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.

Zacks Equity Research

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

Here is how Aveanna Healthcare (AVAH) and Alcon (ALC) have performed compared to their sector so far this year.

Zacks Equity Research

Alcon (ALC) Inks Buyout Deal to Expand Its Glaucoma Portfolio

Alcon (ALC) announces the closing of its deal to acquire BELKIN Vision. Per the terms of the agreement, Alcon will have access to BELKIN Vision's Direct Selective Laser Trabeculoplasty technology.